Wynyard targets Aussie revenue with dual listing on ASX
“Listing on ASX will enable more Australian and foreign investors to hold Wynyard stock, participate in the company's growth and increase the attractiveness of Wynyard shares."
“Listing on ASX will enable more Australian and foreign investors to hold Wynyard stock, participate in the company's growth and increase the attractiveness of Wynyard shares."
Following 21 years of business, a successful IPO pitch and global expansion - Orion Health has today began trading on the NZX Main Board and ASX.
If all goes to plan, the NZX growth market, a new market for growing companies, will launch mid-year.